350 related articles for article (PubMed ID: 20541036)
1. What made sesquiterpene lactones reach cancer clinical trials?
Ghantous A; Gali-Muhtasib H; Vuorela H; Saliba NA; Darwiche N
Drug Discov Today; 2010 Aug; 15(15-16):668-78. PubMed ID: 20541036
[TBL] [Abstract][Full Text] [Related]
2. Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.
Ren Y; Yu J; Kinghorn AD
Curr Med Chem; 2016; 23(23):2397-420. PubMed ID: 27160533
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.
Zhang S; Won YK; Ong CN; Shen HM
Curr Med Chem Anticancer Agents; 2005 May; 5(3):239-49. PubMed ID: 15992352
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on sesquiterpene lactones in inflammation and cancer.
Merfort I
Curr Drug Targets; 2011 Oct; 12(11):1560-73. PubMed ID: 21561425
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances on Cytotoxic Sesquiterpene Lactones.
Quintana J; Estévez F
Curr Pharm Des; 2018; 24(36):4355-4361. PubMed ID: 30659534
[TBL] [Abstract][Full Text] [Related]
6. Sesquiterpene lactones from Saussurea involucrata.
Xiao W; Li X; Li N; Bolati M; Wang X; Jia X; Zhao Y
Fitoterapia; 2011 Oct; 82(7):983-7. PubMed ID: 21641973
[TBL] [Abstract][Full Text] [Related]
7. Isodeoxyelephantopin, a Sesquiterpene Lactone Induces ROS Generation, Suppresses NF-κB Activation, Modulates LncRNA Expression and Exhibit Activities Against Breast Cancer.
Verma SS; Rai V; Awasthee N; Dhasmana A; Rajalaksmi DS; Nair MS; Gupta SC
Sci Rep; 2019 Nov; 9(1):17980. PubMed ID: 31784542
[TBL] [Abstract][Full Text] [Related]
8. The role of oxidative stress in anticancer activity of sesquiterpene lactones.
Gach K; Długosz A; Janecka A
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):477-86. PubMed ID: 25656627
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention.
Cheikh IA; El-Baba C; Youssef A; Saliba NA; Ghantous A; Darwiche N
Expert Opin Drug Discov; 2022 Dec; 17(12):1377-1405. PubMed ID: 36373806
[TBL] [Abstract][Full Text] [Related]
10. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide.
Kreuger MR; Grootjans S; Biavatti MW; Vandenabeele P; D'Herde K
Anticancer Drugs; 2012 Oct; 23(9):883-96. PubMed ID: 22797176
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
12. Deoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways.
Mehmood T; Maryam A; Ghramh HA; Khan M; Ma T
Molecules; 2017 Jun; 22(6):. PubMed ID: 28635648
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of some natural and synthetic sesquiterpene lactones.
Bruno M; Rosselli S; Maggio A; Raccuglia RA; Bastow KF; Wu CC; Lee KH
Planta Med; 2005 Dec; 71(12):1176-8. PubMed ID: 16395659
[TBL] [Abstract][Full Text] [Related]
14. New sesquiterpene lactones from Glechoma hederacea L. and their cytotoxic effects on human cancer cell lines.
Kim J; Lee I; Ha D; Seo J; Min B; Yoo I; Bae K
Planta Med; 2011 Jun; 77(9):955-7. PubMed ID: 21243589
[TBL] [Abstract][Full Text] [Related]
15. [Structure modification on sesquiterpene lactones from Elephantopus scaber].
Liang QL; Min ZD
Yao Xue Xue Bao; 2007 Nov; 42(11):1159-61. PubMed ID: 18300472
[TBL] [Abstract][Full Text] [Related]
16. Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity.
Babaei G; Aliarab A; Abroon S; Rasmi Y; Aziz SG
Biomed Pharmacother; 2018 Oct; 106():239-246. PubMed ID: 29966966
[TBL] [Abstract][Full Text] [Related]
17. Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
Ren Y; Kinghorn AD
J Med Chem; 2020 Dec; 63(24):15410-15448. PubMed ID: 33289552
[TBL] [Abstract][Full Text] [Related]
18. Supercritical CO
Baixinho JP; Anastácio JD; Ivasiv V; Cankar K; Bosch D; Menezes R; de Roode M; Santos CND; Matias AA; Fernández N
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925241
[No Abstract] [Full Text] [Related]
19. Structure-Activity Relationships of Cytotoxic Lactones as Inhibitors and Mechanisms of Action.
Torrens F; Castellano G
Curr Drug Discov Technol; 2020; 17(2):166-182. PubMed ID: 30621564
[TBL] [Abstract][Full Text] [Related]
20. Costunolide-A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential.
Kim DY; Choi BY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
